Renal manifestations of systemic and chronic disease
Which kidney lesion each systemic disease causes (glomerular, tubular, vascular or obstructive), the urine and serology pattern that points to it, the conditions examiners pair (myeloma, amyloid, sarcoid, HIV, hepatitis, cirrhosis, sickle cell), and when to biopsy.
Tier 2Condition
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Systemic disease reaches the kidney through four compartments: glomeruli (proteinuria, haematuria), tubules and interstitium (sterile pyuria, electrolyte and acid-base disorders), vessels (hypertension, TMA, infarction) and the urinary tract (stones, obstruction).
- The urine is the quickest guide: dipstick, microscopy, ACR and PCR, plus complement, serology and free light chains.
- Kidney biopsy settles it when the cause is unclear, function is falling or treatment depends on the lesion.
Loading the rest of the note…
Finished reading?
Sources
- Therapeutic Guidelines: Kidney and UrinaryAU/NZTherapeutic Guidelines Ltd, 2026
- Bose B, Carter SA, Abdy ME et al. CARI Guidelines commentary on the KDIGO clinical practice guideline for the management of glomerular diseases. Nephrology 2025;30(9):e70119AU/NZCARI Guidelines (Australian and New Zealand Society of Nephrology), 2025
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International 2021;100(4S):S1-S276Kidney Disease Improving Global Outcomes, 2021 (being updated chapter by chapter; base document still current, checked November 2026)
- KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis. Kidney International 2024;105(1S):S1-S69Kidney Disease Improving Global Outcomes, 2024 (current, checked November 2026)
- KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis. Kidney International 2024;105(3S):S71-S116Kidney Disease Improving Global Outcomes, 2024
- KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD. Kidney International 2022;102(6S):S129-S205Kidney Disease Improving Global Outcomes, 2022
- Nadim MK et al. Acute kidney injury in patients with cirrhosis: ADQI and ICA joint consensus. J Hepatol 2024;81:163-83Journal of Hepatology, 2024
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback